Genzyme Corporation Completes Sale of Pharmaceuticals Business to International Chemical Investors Group

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme Corporation (Nasdaq: GENZ) today announced that it has completed the sale of its pharmaceutical intermediates business to International Chemical Investors Group (ICIG).

MORE ON THIS TOPIC